Anti-Hypertensive Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery
出 版 商:TBRC
出版日期:2020/09/09
頁 數:200頁
文件格式:PDF
價 格:
USD 4,000 (Single-User License)
USD 6,000 (Multi-User License)
USD 8,000 (Global-User License)
USD 4,000 (Hard copy)
USD 6,000 (Multi-User License)
USD 8,000 (Global-User License)
USD 4,000 (Hard copy)
Anti-Hypertensive Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global anti-hypertensive drugs market as it emerges from the Covid 19 shut down.
Reasons to Purchase
‧ Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
‧ Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
‧ Create regional and country strategies on the basis of local data and analysis.
‧ Identify growth segments for investment.
‧ Outperform competitors using forecast data and the drivers and trends shaping the market.
‧ Understand customers based on the latest market research findings.
‧ Benchmark performance against key competitors.
‧ Utilize the relationships between key data sets for superior strategizing.
‧ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
‧ Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the anti-hypertensive drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Anti-Hypertensive Drugs Market Global Report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
‧ The Market Characteristics section of the report defines and explains the market.
‧ The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
‧ Market segmentations break down market into sub markets.
‧ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
‧ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
‧ The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered: 1) By Therapeutics: Diuretics; Angiotensin Receptor Blockers (ARBs); Angiotensin Converting Enzyme (ACE) Inhibitors; Beta Blockers; Alpha Blockers; Calcium Channel Blockers; Renin Inhibitors; Vasodilators
2) By Disease source: Primary Hypertension; Secondary Hypertension
3) By End users: Hospitals; Clinics; Homecare
Companies Mentioned: Merck & Co.; Astra Zeneca Plc; Daiichi Sankyo Company Limited; Johnson & Johnson Ltd.; Pfizer
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
‧ Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
‧ Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
‧ Create regional and country strategies on the basis of local data and analysis.
‧ Identify growth segments for investment.
‧ Outperform competitors using forecast data and the drivers and trends shaping the market.
‧ Understand customers based on the latest market research findings.
‧ Benchmark performance against key competitors.
‧ Utilize the relationships between key data sets for superior strategizing.
‧ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
‧ Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the anti-hypertensive drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Anti-Hypertensive Drugs Market Global Report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
‧ The Market Characteristics section of the report defines and explains the market.
‧ The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
‧ Market segmentations break down market into sub markets.
‧ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
‧ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
‧ The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered: 1) By Therapeutics: Diuretics; Angiotensin Receptor Blockers (ARBs); Angiotensin Converting Enzyme (ACE) Inhibitors; Beta Blockers; Alpha Blockers; Calcium Channel Blockers; Renin Inhibitors; Vasodilators
2) By Disease source: Primary Hypertension; Secondary Hypertension
3) By End users: Hospitals; Clinics; Homecare
Companies Mentioned: Merck & Co.; Astra Zeneca Plc; Daiichi Sankyo Company Limited; Johnson & Johnson Ltd.; Pfizer
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
1. Executive Summary
2. Anti-Hypertensive Drugs Market Characteristics
3. Anti-Hypertensive Drugs Market Size And Growth
3.1. Global Anti-Hypertensive Drugs Historic Market, 2015-2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Anti-Hypertensive Drugs Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Anti-Hypertensive Drugs Market Segmentation
4.1. Global Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Diuretics
Angiotensin Receptor Blockers (ARBs)
Angiotensin Converting Enzyme (ACE) Inhibitors
Beta Blockers
Alpha Blockers
Calcium Channel Blockers
Renin Inhibitors
Vasodilators
4.2. Global Anti-Hypertensive Drugs Market, Segmentation By Disease source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Primary Hypertension
Secondary Hypertension
4.3. Global Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Hospitals
Clinics
Homecare
5. Anti-Hypertensive Drugs Market Regional And Country Analysis
5.1. Global Anti-Hypertensive Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Anti-Hypertensive Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6. Asia-Pacific Anti-Hypertensive Drugs Market
6.1. Asia-Pacific Anti-Hypertensive Drugs Market Overview
6.2. Asia-Pacific Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
7. China Anti-Hypertensive Drugs Market
7.1. China Anti-Hypertensive Drugs Market Overview
7.2. China Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
8. India Anti-Hypertensive Drugs Market
8.1. India Anti-Hypertensive Drugs Market Overview
8.2. India Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9. Japan Anti-Hypertensive Drugs Market
9.1. Japan Anti-Hypertensive Drugs Market Overview
9.2. Japan Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10. Australia Anti-Hypertensive Drugs Market
10.1. Australia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11. Indonesia Anti-Hypertensive Drugs Market
11.1. Indonesia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12. South Korea Anti-Hypertensive Drugs Market
12.1. South Korea Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13. Western Europe Anti-Hypertensive Drugs Market
13.1. Western Europe Anti-Hypertensive Drugs Market Overview
13.2. Western Europe Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14. UK Anti-Hypertensive Drugs Market
14.1. UK Anti-Hypertensive Drugs Market Overview
14.2. UK Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15. Germany Anti-Hypertensive Drugs Market
15.1. Germany Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16. France Anti-Hypertensive Drugs Market
16.4. France Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17. Eastern Europe Anti-Hypertensive Drugs Market
17.1. Eastern Europe Anti-Hypertensive Drugs Market Overview
17.2. Eastern Europe Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18. Russia Anti-Hypertensive Drugs Market
18.1. Russia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19. North America Anti-Hypertensive Drugs Market
19.1. North America Anti-Hypertensive Drugs Market Overview
19.2. North America Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20. USA Anti-Hypertensive Drugs Market
20.1. USA Anti-Hypertensive Drugs Market Overview
20.2. USA Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21. South America Anti-Hypertensive Drugs Market
21.1. South America Anti-Hypertensive Drugs Market Overview
21.2. South America Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22. Brazil Anti-Hypertensive Drugs Market
22.1. Brazil Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23. Middle East Anti-Hypertensive Drugs Market
23.1. Middle East Anti-Hypertensive Drugs Market Overview
23.2. Middle East Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24. Africa Anti-Hypertensive Drugs Market
24.1. Africa Anti-Hypertensive Drugs Market Overview
24.2. Africa Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
25. Anti-Hypertensive Drugs Market Competitive Landscape And Company Profiles
25.1. Anti-Hypertensive Drugs Market Competitive Landscape
25.2. Anti-Hypertensive Drugs Market Company Profiles
25.2.1. Merck & Co. Inc.
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Astra Zeneca Plc
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Daiichi Sankyo Company Limited
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Johnson & Johnson Ltd.
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Pfizer, Inc.
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Anti-Hypertensive Drugs Market
27. Anti-Hypertensive Drugs Market Trends And Strategies
28. Product Pipeline Analysis
29. Anti-Hypertensive Drugs Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. The Business Research Company
30.5. Copyright And Disclaimer
2. Anti-Hypertensive Drugs Market Characteristics
3. Anti-Hypertensive Drugs Market Size And Growth
3.1. Global Anti-Hypertensive Drugs Historic Market, 2015-2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Anti-Hypertensive Drugs Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Anti-Hypertensive Drugs Market Segmentation
4.1. Global Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Diuretics
Angiotensin Receptor Blockers (ARBs)
Angiotensin Converting Enzyme (ACE) Inhibitors
Beta Blockers
Alpha Blockers
Calcium Channel Blockers
Renin Inhibitors
Vasodilators
4.2. Global Anti-Hypertensive Drugs Market, Segmentation By Disease source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Primary Hypertension
Secondary Hypertension
4.3. Global Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Hospitals
Clinics
Homecare
5. Anti-Hypertensive Drugs Market Regional And Country Analysis
5.1. Global Anti-Hypertensive Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Anti-Hypertensive Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6. Asia-Pacific Anti-Hypertensive Drugs Market
6.1. Asia-Pacific Anti-Hypertensive Drugs Market Overview
6.2. Asia-Pacific Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
7. China Anti-Hypertensive Drugs Market
7.1. China Anti-Hypertensive Drugs Market Overview
7.2. China Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
8. India Anti-Hypertensive Drugs Market
8.1. India Anti-Hypertensive Drugs Market Overview
8.2. India Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9. Japan Anti-Hypertensive Drugs Market
9.1. Japan Anti-Hypertensive Drugs Market Overview
9.2. Japan Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10. Australia Anti-Hypertensive Drugs Market
10.1. Australia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11. Indonesia Anti-Hypertensive Drugs Market
11.1. Indonesia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12. South Korea Anti-Hypertensive Drugs Market
12.1. South Korea Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13. Western Europe Anti-Hypertensive Drugs Market
13.1. Western Europe Anti-Hypertensive Drugs Market Overview
13.2. Western Europe Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14. UK Anti-Hypertensive Drugs Market
14.1. UK Anti-Hypertensive Drugs Market Overview
14.2. UK Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15. Germany Anti-Hypertensive Drugs Market
15.1. Germany Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16. France Anti-Hypertensive Drugs Market
16.4. France Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17. Eastern Europe Anti-Hypertensive Drugs Market
17.1. Eastern Europe Anti-Hypertensive Drugs Market Overview
17.2. Eastern Europe Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18. Russia Anti-Hypertensive Drugs Market
18.1. Russia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19. North America Anti-Hypertensive Drugs Market
19.1. North America Anti-Hypertensive Drugs Market Overview
19.2. North America Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20. USA Anti-Hypertensive Drugs Market
20.1. USA Anti-Hypertensive Drugs Market Overview
20.2. USA Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21. South America Anti-Hypertensive Drugs Market
21.1. South America Anti-Hypertensive Drugs Market Overview
21.2. South America Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22. Brazil Anti-Hypertensive Drugs Market
22.1. Brazil Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23. Middle East Anti-Hypertensive Drugs Market
23.1. Middle East Anti-Hypertensive Drugs Market Overview
23.2. Middle East Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24. Africa Anti-Hypertensive Drugs Market
24.1. Africa Anti-Hypertensive Drugs Market Overview
24.2. Africa Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
25. Anti-Hypertensive Drugs Market Competitive Landscape And Company Profiles
25.1. Anti-Hypertensive Drugs Market Competitive Landscape
25.2. Anti-Hypertensive Drugs Market Company Profiles
25.2.1. Merck & Co. Inc.
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Astra Zeneca Plc
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Daiichi Sankyo Company Limited
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Johnson & Johnson Ltd.
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Pfizer, Inc.
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Anti-Hypertensive Drugs Market
27. Anti-Hypertensive Drugs Market Trends And Strategies
28. Product Pipeline Analysis
29. Anti-Hypertensive Drugs Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. The Business Research Company
30.5. Copyright And Disclaimer